TAK
NYSE
$17.05
Takeda Pharmaceutical Company (TAK)
Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.
Sector:
Healthcare
Buy
Target: $21.02 (+23.28%)
Market Cap
$51B
PEG Ratio
0.46
Forward P/E
11.10
P/E Ratio
40.49
Price Chart
Valuation
Market Cap$51B
P/E40.49
Forward P/E11.10
PEG0.46
P/S0.01
P/B1.14
Profitability
Gross Profit (TTM)$18B
EBITDA$8.63B
Profit Margin3.3%
Operating Margin9.3%
EPS$0.41
Financial Health
Free Cash Flow Yield7.73%
Dividend Yield3.60%
Growth & Risk
EPS 5Y CAGR-18.14%
FCF 5Y CAGR-11.28%
Dividends 5Y CAGR+18.98%
Beta (5Y)0.22
Sharpe Ratio0.80